NCT06245980招募中不适用
Role of SGLT2I in Diabetic Patients With Myocardial Infarction
Dongying Zhang1 个研究点 分布在 1 个国家目标入组 1,200 人开始时间: 2018年1月1日最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,200
- 试验地点
- 1
- 主要终点
- Heart failure readmission
研究概览
简要总结
Role of sglt2I in diabetic patients with myocardial infarction
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 90 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Acute myocardial infarction patients
- •Type 2 diabetics.
排除标准
- •Patients undergoing coronary artery bypass grafting (CABG).
- •Severe valvular heart disease.
- •Contraindications of secondary medical preventive therapy for myocardial infarction, such as β-blockers, angiotensin-converting enzyme inhibitors (ACEI)/ angiotensin-converting enzyme inhibitors (ARBs), antiplatelets, and statins.
- •Previously used SGLT2i.
- •Severe hepatic and renal insufficiency.
研究组 & 干预措施
With SGLT2I
干预措施: SGLT2 inhibitor (Drug)
结局指标
主要结局
Heart failure readmission
时间窗: 24months
Heart failure readmission
MACE
时间窗: 24months
cardiovascular death and heart failure and myocardial infarction
次要结局
- cardiovascular death(24months)
- Recurrent myocardial infarction(24months)
研究者
Dongying Zhang
Professor
Chongqing Medical University
研究点 (1)
Loading locations...
相似试验
已完成
3 期
SGLT-2 Inhibitor and Myocardial Perfusion, Function and Metabolism in T2 DM Patients at High Cardiovascular RiskType2 Diabetes MellitusNCT03151343Caroline M Kistorp92
尚未招募
不适用
The effect of SGLT2 inhibitor on diabetic cardiac autonomic neuropathydiabetes mellitusJPRN-UMIN000033541Sakakibara Heart Institute200
招募中
不适用
The Effect of SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac Function in T2DM Patients With CAD (EpiCAD)Coronary Artery DiseaseNCT06128096Clinical Research Centre, Malaysia360
Unknown
不适用
Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor MutationsPrediabetes (Insulin Resistance, Impaired Glucose Tolerance)Familiar Hypocalcuric HypercalcemiaHealthy VolunteersType 2 Diabetes MellitusType 1 Diabetes MellitusNCT02023489Medical University of Vienna90
Unknown
4 期
Effects of SGLT2 Inhibitor on Type 2 Diabetic Patients Undergoing Cardiac SurgeryCardiac SurgeryDiabetes Mellitus, Type 2NCT04340908Hongchang Guo500
